Brief: Innovate Biopharma Says As Of March 31, 2019, Had Estimated Unaudited Cash And Cash Equivalents Of $11.5 Mln

9 Meters Biopharma

26/04/2019 22:44

April 26 (Reuters) - Innovate Biopharmaceuticals Inc
 INNT.O :
    * INNOVATE BIOPHARMACEUTICALS INC SAYS AS OF MARCH 31, 2019,
CO
HAD ESTIMATED UNAUDITED CASH AND CASH EQUIVALENTS OF $11.5
MILLION - SEC FILING

Source text: [https://bit.ly/2L9AOYK]
Further company coverage:  INNT.O 

 (Reuters.Briefs@thomsonreuters.com)